Tracking a promising leukemia treatment in everyday practice
NCT ID NCT05999877
Summary
This study is observing how patients with chronic lymphocytic leukemia (CLL) do on the drug acalabrutinib in real-world Spanish hospitals. It includes about 192 patients who were either starting their first treatment or switching from a similar drug due to side effects. The goal is to see how long patients stay on the drug, how well they tolerate it, and their health outcomes over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Almería, Andalusia, 4009, Spain
-
Research Site
Córdoba, Andalusia, 14004, Spain
-
Research Site
Granada, Andalusia, 18014, Spain
-
Research Site
Jaén, Andalusia, 23007, Spain
-
Research Site
Marbella, Andalusia, 29603, Spain
-
Research Site
Málaga, Andalusia, 29010, Spain
-
Research Site
Seville, Andalusia, 41013, Spain
-
Research Site
Zaragoza, Aragon, 50009, Spain
-
Research Site
Palma de Mallorca, Balearic Islands, 7010, Spain
-
Research Site
Palma de Mallorca, Balearic Islands, 7198, Spain
-
Research Site
Las Palmas de Gran Canaria, Canary Islands, 35016, Spain
-
Research Site
Las Palmas de Gran Canaria, Canary Islands, 35019, Spain
-
Research Site
San Cristóbal de La Laguna, Canary Islands, 38320, Spain
-
Research Site
Santander, Cantabria, 39008, Spain
-
Research Site
Salamanca, Castille and León, 37007, Spain
-
Research Site
Segovia, Castille and León, 40002, Spain
-
Research Site
Valladolid, Castille and León, 47003, Spain
-
Research Site
Valladolid, Castille and León, 47012, Spain
-
Research Site
Guadalajara, Castille-La Mancha, 19002, Spain
-
Research Site
Toledo, Castille-La Mancha, 45004, Spain
-
Research Site
Barcelona, Catalonia, 8003, Spain
-
Research Site
Barcelona, Catalonia, 8025, Spain
-
Research Site
Barcelona, Catalonia, 8035, Spain
-
Research Site
Barcelona, Catalonia, 8036, Spain
-
Research Site
Granollers, Catalonia, 8402, Spain
-
Research Site
L'Hospitalet de Llobregat, Catalonia, 8908, Spain
-
Research Site
Lleida, Catalonia, 25198, Spain
-
Research Site
Terrassa, Catalonia, 8221, Spain
-
Research Site
Ourense, Galicia, 32005, Spain
-
Research Site
Santiago de Compostela, Galicia, 15706, Spain
-
Research Site
Vigo, Galicia, 36312, Spain
-
Research Site
Madrid, Madrid, 28006, Spain
-
Research Site
Madrid, Madrid, 28031, Spain
-
Research Site
Madrid, Madrid, 28034, Spain
-
Research Site
Madrid, Madrid, 28040, Spain
-
Research Site
Madrid, Madrid, 28041, Spain
-
Research Site
Madrid, Madrid, 28046, Spain
-
Research Site
Madrid, Madrid, 28905, Spain
-
Research Site
Madrid, Madrid, 28911, Spain
-
Research Site
Majadahonda, Madrid, 28222, Spain
-
Research Site
El Palmar, Murcia, 30120, Spain
-
Research Site
Murcia, Murcia, 30008, Spain
-
Research Site
Oviedo, Principality of Asturias, 33011, Spain
-
Research Site
Alicante, Valencia, 3010, Spain
-
Research Site
Valencia, Valencia, 46010, Spain
-
Research Site
Valencia, Valencia, 46014, Spain
-
Research Site
Valencia, Valencia, 46026, Spain
Conditions
Explore the condition pages connected to this study.